Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Kulah, Canan ^a   Aktas, Elif ^a   Comert, Fusun ^a   Ozlu, Nagihan ^a   Akyar, Isin ^b   Ankarali, Handan ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b Acibadem Labmed   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANALYTICAL ERROR; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIUM ISOLATE; BROTH DILUTION; COMPUTER SYSTEM; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DISK DIFFUSION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERFORMANCE MEASUREMENT SYSTEM; STRAIN IDENTIFICATION; VALIDATION PROCESS; ANTIBIOTIC RESISTANCE; COMPARATIVE STUDY; DIAGNOSTIC ERROR; DRUG EFFECT; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PREDICTION AND FORECASTING; QUALITY CONTROL; STANDARD; STATISTICS;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; DIAGNOSTIC ERRORS; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; PREDICTIVE VALUE OF TESTS; QUALITY CONTROL;

EID: 64049114329     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-30     Document Type: Article

References (28)

1. Bergogne-Berezin E Towner KJ Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features Clin Microbiol Rev 1996, 9:148-165. 172888 8964033
2. Tsakris A Pantazi A Pournaras S Maniatis A Polyzou A Sofianou D Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system J Clin Microbiol 2000, 38(9):3505-7. 87420 10970417
3. Poirel L Nordmann P Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology Clin Microbiol Infect 2006, 12(9):826-836. 10.1111/j.1469-0691.2006.01456.x 16882287
4. Bou G Cervero G Dominguez MA Quereda C Martinez-Beltran J PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii Clin Microbiol Infect 2000, 6(12):635-43. 10.1046/j.1469-0691.2000.00181.x 11284921
5. Corbella X Montero A Pujol M Domínguez MA Ayats J Argerich MJ Garrigosa F Ariza J Gudiol F Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii J Clin Microbiol 2000, 38(11):4086-95. 87546 11060073
6. He'ritier C Dubouix A Poirel L Marty N Nordmann P A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58 J Antimicrob Chemother 2005, 55:115-118. 10.1093/jac/dkh500 15590718
7. Pournaras S Markogiannakis A Ikonomidis A Kondyli L Bethimouti K Maniatis AN Legakis NJ Tsakris A Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit J Antimicrob Chemother 2006, 57:557-561. 10.1093/jac/dkl004 16431857
8. Cisneros JM Reyes MJ Pachon J Becerril B Caballero FJ García-Garmendía JL Ortiz C Cobacho AR Bacteremia due to Acinetobacter baumannii: Epidemiology, clinical and prognostic features Clin Infect Dis 1996, 22:1026-1032. 8783704
9. Donay JL Mathieu D Fernandes P Prégermain C Bruel P Wargnier A Casin I Weill FX Lagrange PH Herrmann JL Evaluation of the automated Phoenix system for potential routine use in the clinical microbiology laboratory J Clin Microbiol 2004, 42(4):1542-6. 387561 15071001 10.1128/ JCM.42.4.1542-1546.2004
10. Schreckenberger PC Daneshvar MI Weyant RS Hollis DG Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods Manual of Clinical Microbiology Washington (DC): ASM Pres Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH 2003:749-779.
11. Clinical and Laboratory Standards Institute Approved standart M100-S16. Performance standards for antimicrobial susceptibility testing Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA 2006.
12. Clinical and Laboratory Standards Institute Approved Standart M7-A6. Methods for dilution antimicrobial susceptibility tests for bacteria that growth aerobically Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA 6 2005.
13. National Committee for Clinical Laboratory Standards Approved guideline M23-A2. Development of in vitro susceptibility testing criteria and quality control parameters National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, USA 2 2001.
14. Goossens H MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: Comparison of antibiotic susceptibilities between countries and centre types. MYSTIC Study Group (European centres only) J Antimicrob Chemother 2000, 46(Supp 2):39-52. 10.1093/jac/46.suppl_2.39 MYSTIC
15. Jones RN Mendes C Turner PJ Masterton R An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997-2004 Diagn Microbiol Infect Dis 2005, 53:247-256. 10.1016/ j.diagmicrobio.2005.10.006 16360548
16. Korten V Ulusoy S Zarakolu P Mete B Turkish MYSTIC Study Group. Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: Results of the MYSTIC Program Diagn Microbiol Infect Dis 2007, 59(4):453-7. 10.1016/j.diagmicrobio.2007.06.016 17888609
17. Eraksoy H Basustaoglu A Korten V Kurt H Ozturk R Ulusoy S Yaman A Yuce A Zarakolu P Turkish MYSTIC Study Group Susceptibility of bacterial isolates from Turkey - a report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program J Chemother 2007, 19(6):650-7. 18230545
18. Perez F Hujer AM Hujer KM Decker BK Rather PN Bonomo RA Global challenge of multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 2007, 51(10):3471-84. 2043292 17646423 10.1128/AAC.01464-06
19. Doern GV Brueggemann AB Perla R Daly J Halkias D Jones RN Saubolle MA Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa J Clin Microbiol 1997, 35(8):2115-2119. 229914 9230393
20. Biedenbach DJ Jones RN Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam Diagn Microbiol Infect Dis 1995, 21:57-60. 10.1016/0732-8893(94)00069-9 7789099
21. Marshall SA Serious interpretive error among three commercial systems for susceptibility testing of aztreonam. Aztreonam Study Group Diagn Microbiol Infect Dis 1995, 22(3):249-51. 10.1016/0732-8893(95)00064-H 8565412
22. Sader HS Fritsche TR Jones RN Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents J Clin Microbiol 2006, 44(3):1101-4. 1393142 16517904 10.1128/ JCM.44.3.1101-1104.2006
23. Steward CD Mohammed JM Swenson JM Stocker SA Williams PP Gaynes RP et al. Antimicrobial susceptibility testing of carbapenems: Multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates J Clin Microbiol 2003, 41:351-8. 149638 12517872 10.1128/JCM.41.1.351-358.2003
24. White RL Kays MB Friedrich LV Brown EW Koonce JR Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels J Clin Microbiol 1991, 29:398-400. 269776 1822083
25. Tenover FC Kalsi RK Williams PP Carey RB Stocker S Lonsway D Rasheed JK Biddle JW McGowan JE Jr Hanna B Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing Emerg Infect Dis 2006, 12(8):1209-13. 16965699
26. Bratu S Mooty M Nichani S Landman D Gullans C Pettinato B Karumudi U Tolaney P Quale J Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and recommendations for detection Antimicrob Agents Chemother 2005, 49:3018-20. 1168646 15980389 10.1128/ AAC.49.7.3018-3020.2005
27. Bratu S Landman D Haag R Recco R Eramo A Alam M Quale J Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium Arch Intern Med 2005, 165:1430-5. 10.1001/archinte.165.12.1430 15983294
28. Endimiani A Luzzaro F Tamborini A Lombardi G Elia V Belloni R Toniolo A Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System New Microbiol 2002, 25(3):323-9. 12173774